4.7 Letter

About the source and consequences of 18F-FDG brain PET hypometabolism in short and long COVID-19

Related references

Note: Only part of the references are listed.
Article Cell & Tissue Engineering

ApoE-Isoform-Dependent SARS-CoV-2 Neurotropism and Cellular Response

Cheng Wang et al.

Summary: The study suggests a potential causal role of ApoE4 in the severity of COVID-19, as tested in human-induced pluripotent stem cell (hiPSC) models for SARS-CoV-2 neurotropism. Increased infection rates of SARS-CoV-2 in ApoE4/4 neurons and astrocytes were observed, with changes in ApoE4 astrocytes upon infection. Remdesivir treatment was effective in inhibiting SARS-CoV2 infection in hiPSC neurons and astrocytes, highlighting the impact of risk factors on COVID-19 severity.

CELL STEM CELL (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

The cerebral network of COVID-19-related encephalopathy: a longitudinal voxel-based 18F-FDG-PET study

Aurelie Kas et al.

Summary: This study examined the longitudinal brain metabolic pattern in COVID-19-related encephalopathy using 18F-FDG-PET/CT. It found a consistent pattern of hypometabolism in various brain regions, with patients presenting with cognitive and behavioral disorders in the acute phase and ongoing cognitive and emotional symptoms 6 months after disease onset.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

18F-FDG brain PET hypometabolism in patients with long COVID

E. Guedj et al.

Summary: In long COVID patients, brain PET scans showed significant hypometabolism in areas including bilateral rectal/orbital gyrus, temporal lobe, brainstem, and cerebellum. These metabolic abnormalities were associated with more functional complaints such as hyposmia/anosmia, memory/cognitive impairment, pain, and insomnia. The study suggests a potential biomarker value in identifying and monitoring long COVID patients, with implications for the impact of ACE drugs and nasal decongestant spray on brain metabolism.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

Letter Radiology, Nuclear Medicine & Medical Imaging

18FDG PET/CT Scan Reveals Hypoactive Orbitofrontal Cortex in Anosmia of COVID-19

Mahboobeh Karimi-Galougahi et al.

ACADEMIC RADIOLOGY (2020)

Editorial Material Neurosciences

PET Imaging as a Tool for Assessing COVID-19 Brain Changes

Igor C. Fontana et al.

TRENDS IN NEUROSCIENCES (2020)

Review Biochemistry & Molecular Biology

Astrocyte Biomarkers in Alzheimer's Disease

Stephen F. Carter et al.

TRENDS IN MOLECULAR MEDICINE (2019)

Article Neurosciences

[18F]FDG PET signal is driven by astroglial glutamate transport

Eduardo R. Zimmer et al.

NATURE NEUROSCIENCE (2017)

Editorial Material Neurosciences

Glucose utilization: still in the synapse

A. Jon Stoessl

NATURE NEUROSCIENCE (2017)

Review Neurosciences

Astrocyte barriers to neurotoxic inflammation

Michael V. Sofroniew

NATURE REVIEWS NEUROSCIENCE (2015)

Article Radiology, Nuclear Medicine & Medical Imaging

Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias

Lisa Mosconi et al.

JOURNAL OF NUCLEAR MEDICINE (2008)

Article Psychiatry

Thalamic and prefrontal FDG uptake in never medicated patients with schizophrenia

DS Lehrer et al.

AMERICAN JOURNAL OF PSYCHIATRY (2005)

Review Radiology, Nuclear Medicine & Medical Imaging

Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease - FDG-PET studies in MCI and AD

L Mosconi

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2005)